BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23306763)

  • 1. [Management of patient with Gaves' orbitopathy].
    Di Fiore A; Paone L; Rendina R; D'Armiento E; Coccaro C; Alessandrini S; Marenco M; Ulisse S
    Clin Ter; 2012 Nov; 163(6):e463-74. PubMed ID: 23306763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.
    Marcocci C; Marinò M
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):325-37. PubMed ID: 22632369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment options for Graves' orbitopathy.
    Marcocci C; Altea MA; Leo M
    Expert Opin Pharmacother; 2012 Apr; 13(6):795-806. PubMed ID: 22404364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.
    Bartalena L; Kahaly GJ; Baldeschi L; Dayan CM; Eckstein A; Marcocci C; Marinò M; Vaidya B; Wiersinga WM;
    Eur J Endocrinol; 2021 Aug; 185(4):G43-G67. PubMed ID: 34297684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Graves' orbitopathy].
    Eckstein A; Esser J
    Klin Monbl Augenheilkd; 2011 May; 228(5):432-8. PubMed ID: 21534176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
    Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves orbitopathy: update on diagnosis and therapy.
    Melcescu E; Horton WB; Kim D; Vijayakumar V; Corbett JJ; Crowder KW; Pitman KT; Uwaifo GI; Koch CA
    South Med J; 2014 Jan; 107(1):34-43. PubMed ID: 24389785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of dysthyroid orbitopathy: a multidisciplinary disease].
    Leray B; Imbert P; Thouvenin D; Boutault F; Caron P
    J Fr Ophtalmol; 2013 Dec; 36(10):874-85. PubMed ID: 24239215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid-associated orbitopathy: who and how to treat.
    Dickinson J; Perros P
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):373-88, ix. PubMed ID: 19328417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Graves ophthalmopathy - 2022 update.
    Jiskra J
    Cas Lek Cesk; 2022; 161(5):198-206. PubMed ID: 36443100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric aspects in Graves' orbitopathy.
    Gogakos AI; Boboridis K; Krassas GE
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():234-44. PubMed ID: 20467370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts regarding Graves' orbitopathy.
    Bartalena L; Tanda ML
    J Intern Med; 2022 Nov; 292(5):692-716. PubMed ID: 35604323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?
    Bartalena L
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):149-52. PubMed ID: 20148907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
    Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Graves' ophthalmopathy.
    Wiersinga WM
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocrine orbitopathy: the present view of a clinical endocrinologist].
    Jiskra J
    Vnitr Lek; 2017; 63(10):690-696. PubMed ID: 29127744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.
    Bartalena L; Baldeschi L; Boboridis K; Eckstein A; Kahaly GJ; Marcocci C; Perros P; Salvi M; Wiersinga WM;
    Eur Thyroid J; 2016 Mar; 5(1):9-26. PubMed ID: 27099835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.